HuagongsheHuagongshe Chemistry Print Report · For research reference only
5-Fluorouracil → [(2S,3S,4S,5S)-3,4-dibenzoyloxy-5-(5-fluoro-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl benzoate
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 5-Fluorouracil | HCID 3385 | — |
| Reactant | Chlorotrimethylsilane | HCID 6397 | — |
| Reactant | Hexamethyldisilazane | HCID 13838 | — |
| Reactant | Tin tetrachloride | HCID 24287 | — |
| Reactant | Ribofuranose, 1-acetate 2,3,5-tribenzoate | HCID 10973190 | — |
| Solvent | Acetonitrile | HCID 6342 | — |
| Product | [(2S,3S,4S,5S)-3,4-dibenzoyloxy-5-(5-fluoro-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl benzoate | HCID 13827065 | 61.9% |
Reaction Steps
To a mixture of 5-fluorouracil (0.85 g, 6.54 mmol) and compound 2 (3.0 g, 5.94 mmol) in anhydrous MeCN (100 ml) were successively added HMDS (1.25 ml, 5.95 mmol), ClSiMe3 (0.6 ml, 4.76 mmol) and SnCl4 (0.83 ml, 7.13 mmol). The resulting clear solution was refluxed for 1 hour when TLC indicated completion of the reaction. The solvent was evaporated and the residue dissolved in EtOAc (250 ml), washed with NaHCO3 and H2O. The EtOAc layer was dried, filtered and evaporated to give a white solid and it was crystallized from CHCl3 /MeOH (1-2%) to give compound 5 (2.11 g, 61.9%) as white crystals: m.p. 208°-209° C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US05559101 |
| Source dataset | uspto-grants-1996_09 |
| ORD ID | ord-53dcae0d336b4abab98031f746b383bc |
| Source note | uspto-grants-1996_09 |